Evolution of the Randomized Clinical Trial in the Era of Precision Oncology
Joseph C. Del Paggio(Thunder Bay Regional Health Sciences Centre), Christopher M. Booth(Queen's University), Bishal Gyawali(Ontario Institute for Cancer Research), Wilma M. Hopman(Queen's University), Vinay Prasad(University of California, San Francisco), Elizabeth A. Eisenhauer(Queen's University), John Berry(University of Plymouth)
Cited by 200
Related Papers
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
|JAMA|2003|1.4k
Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer
|JAMA|2011|632
Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval
|JAMA Internal Medicine|2017|497
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
|British Journal of Cancer|2014|470